# Senti Biosciences Holdings, Inc.: filings

SNTI · Nasdaq · CIK 1854270 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/snti.md) · [Financials](/companies/snti/financials.md) · [Filings](/companies/snti/filings.md) · [Insiders](/companies/snti/insiders.md)

## Reports and events: 127 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 77, 4 59, 424B3 28, 3 27, 10-Q 17, CORRESP 13, EFFECT 13, SCHEDULE 13D/A 9, DEFA14A 8, SC 13G 8, UPLOAD 8, 425 6, POS AM 6, SC 13G/A 6, 10-K 5, S-8 5, SCHEDULE 13G/A 5, ARS 4, DEF 14A 4, S-8 POS 4, 424B5 3, S-1 3, S-1/A 3, S-3 3, S-3/A 3, S-4/A 3, SCHEDULE 13G 3, 10-K/A 2, 10-Q/A 2, D 2, DEFM14A 2, PRE 14A 2, PRER14A 2, SCHEDULE 13D 2, SEC STAFF LETTER 2, 144 1, 15-12G 1, 4/A 1, 8-A12B 1, 8-K12B 1, 8-K/A 1, CERT 1, DRS 1, PREM14A 1, S-4 1, SC 13D 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 16:17 ET | [8-K](/filings/0001140361-26-040772.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-26-040772 |
| 2026-10-15 | 16:02 ET | [8-K](/filings/0001628280-26-065992.md) | 5.07 Shareholder vote results | 0001628280-26-065992 |
| 2026-10-13 | 16:01 ET | [8-K](/filings/0001628280-26-065685.md) | 8.01 Other events | 0001628280-26-065685 |
| 2026-09-24 | 16:03 ET | [8-K](/filings/0001628280-26-063369.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-063369 |
| 2026-09-11 | 17:00 ET | [SCHEDULE 13D/A](/filings/0000902664-26-003795.md) | Ownership report, active investor, amended | 0000902664-26-003795 |
| 2026-09-04 | 06:01 ET | [8-K](/filings/0001628280-26-060600.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-26-060600 |
| 2026-09-02 | 16:29 ET | [8-K](/filings/0001628280-26-060124.md) | 1.01 Entry into a material agreement; 3.01 Delisting notice | 0001628280-26-060124 |
| 2026-08-20 | 16:25 ET | [8-K](/filings/0001628280-26-058258.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001628280-26-058258 |
| 2026-08-14 | 16:10 ET | [10-Q](/filings/0001628280-26-057110.md) | Quarterly report, period 2026-06-30 | 0001628280-26-057110 |
| 2026-07-16 | 13:56 ET | [SCHEDULE 13D/A](/filings/0000902664-26-003126.md) | Ownership report, active investor, amended | 0000902664-26-003126 |
| 2026-07-15 | 07:32 ET | [8-K](/filings/0001628280-26-048248.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 5.01 Change in control; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-048248 |
| 2026-05-26 | 16:02 ET | [8-K](/filings/0001628280-26-038058.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-26-038058 |
| 2026-05-14 | 16:17 ET | [10-Q](/filings/0001628280-26-035126.md) | Quarterly report, period 2026-03-31 | 0001628280-26-035126 |
| 2026-05-14 | 08:48 ET | [8-K](/filings/0001628280-26-034834.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-034834 |
| 2026-05-04 | 17:00 ET | [SCHEDULE 13D/A](/filings/0000902664-26-002262.md) | Ownership report, active investor, amended | 0000902664-26-002262 |
| 2026-05-01 | 16:06 ET | [8-K](/filings/0001628280-26-029320.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.01 Change in control; 9.01 Financial statements and exhibits | 0001628280-26-029320 |
| 2026-04-29 | 16:41 ET | [10-K/A](/filings/0001628280-26-028429.md) | Annual report, amended, period 2025-12-31 | 0001628280-26-028429 |
| 2026-04-16 | 16:50 ET | [SCHEDULE 13D/A](/filings/0001104659-26-044433.md) | Ownership report, active investor, amended | 0001104659-26-044433 |
| 2026-04-01 | 16:31 ET | [8-K](/filings/0001628280-26-022824.md) | 8.01 Other events | 0001628280-26-022824 |
| 2026-03-31 | 17:58 ET | [SCHEDULE 13D/A](/filings/0001072613-26-000301.md) | Ownership report, active investor, amended | 0001072613-26-000301 |
| 2026-03-27 | 08:06 ET | [10-K](/filings/0001628280-26-021580.md) | Annual report, period 2025-12-31 | 0001628280-26-021580 |
| 2026-03-27 | 08:01 ET | [8-K](/filings/0001628280-26-021578.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-021578 |
| 2026-03-19 | 16:02 ET | [8-K](/filings/0001628280-26-019789.md) | 1.01 Entry into a material agreement | 0001628280-26-019789 |
| 2026-01-20 | 16:05 ET | [SCHEDULE 13D/A](/filings/0000902664-26-000314.md) | Ownership report, active investor, amended | 0000902664-26-000314 |
| 2025-12-09 | 07:04 ET | [8-K](/filings/0001628280-25-055953.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-055953 |
| 2025-11-13 | 17:09 ET | [10-Q](/filings/0001628280-25-052125.md) | Quarterly report, period 2025-09-30 | 0001628280-25-052125 |
| 2025-11-13 | 16:38 ET | [8-K](/filings/0001628280-25-052083.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-052083 |
| 2025-09-02 | 08:15 ET | [SCHEDULE 13D/A](/filings/0000902664-25-003924.md) | Ownership report, active investor, amended | 0000902664-25-003924 |
| 2025-08-07 | 08:09 ET | [10-Q](/filings/0001854270-25-000090.md) | Quarterly report, period 2025-06-30 | 0001854270-25-000090 |
| 2025-08-07 | 08:06 ET | [8-K](/filings/0001854270-25-000088.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001854270-25-000088 |
| 2025-07-18 | 08:56 ET | [8-K](/filings/0001854270-25-000077.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001854270-25-000077 |
| 2025-06-30 | 16:02 ET | [8-K](/filings/0001854270-25-000073.md) | 5.07 Shareholder vote results | 0001854270-25-000073 |
| 2025-06-18 | 07:05 ET | [8-K](/filings/0001854270-25-000069.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001854270-25-000069 |
| 2025-05-06 | 16:48 ET | [10-Q](/filings/0001854270-25-000065.md) | Quarterly report, period 2025-03-31 | 0001854270-25-000065 |
| 2025-05-06 | 16:42 ET | [8-K](/filings/0001854270-25-000062.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001854270-25-000062 |
| 2025-04-30 | 16:24 ET | [DEF 14A](/filings/0001854270-25-000054.md) | Proxy statement, period 2025-06-25 | 0001854270-25-000054 |
| 2025-04-28 | 07:12 ET | [8-K](/filings/0001854270-25-000046.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001854270-25-000046 |
| 2025-03-24 | 06:02 ET | [8-K](/filings/0001140361-25-009939.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-009939 |
| 2025-03-20 | 17:08 ET | [10-K](/filings/0001854270-25-000042.md) | Annual report, period 2024-12-31 | 0001854270-25-000042 |
| 2025-03-20 | 16:21 ET | [8-K](/filings/0001854270-25-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001854270-25-000038 |
| 2025-03-17 | 18:35 ET | [SCHEDULE 13D](/filings/0001104659-25-024530.md) | Ownership report, active investor | 0001104659-25-024530 |
| 2025-03-17 | 15:01 ET | [SCHEDULE 13D/A](/filings/0001079973-25-000398.md) | Ownership report, active investor, amended | 0001079973-25-000398 |
| 2025-03-13 | 16:31 ET | [SCHEDULE 13D](/filings/0001079973-25-000383.md) | Ownership report, active investor | 0001079973-25-000383 |
| 2025-03-10 | 19:00 ET | [SCHEDULE 13D/A](/filings/0001072613-25-000223.md) | Ownership report, active investor, amended | 0001072613-25-000223 |
| 2025-03-10 | 16:01 ET | [8-K](/filings/0001140361-25-007862.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-007862 |
| 2025-03-07 | 17:18 ET | [8-K](/filings/0001140361-25-007658.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-25-007658 |
| 2025-02-25 | 16:34 ET | [8-K](/filings/0001854270-25-000008.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001854270-25-000008 |
| 2025-02-06 | 17:30 ET | [8-K](/filings/0001628280-25-004293.md) | 5.02 Departure or appointment of officers or directors | 0001628280-25-004293 |
| 2025-01-27 | 07:30 ET | [DEF 14A](/filings/0001140361-25-001942.md) | Proxy statement, period 2025-03-06 | 0001140361-25-001942 |
| 2025-01-06 | 16:01 ET | [8-K](/filings/0001140361-25-000337.md) | 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-000337 |

Page 1 of 3. [Older](/companies/snti/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:38 ET. No prices; not investment advice.